Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Spinal muscular atrophy: present state.

H Schmalbruch1, G Haase

  • 1Department of Medical Physiology, University of Copenhagen, Denmark. H.Schmalbruch@mfi.ku.dk

Brain Pathology (Zurich, Switzerland)
|April 17, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence and characterization of azole-resistant Aspergillus fumigatus in patients with cystic fibrosis: a prospective multicentre study in Germany.

The Journal of antimicrobial chemotherapy·2018
Same author

A point mutation in the extracellular domain of L1 blocks its capacity to confer metastasis in colon cancer cells via CD10.

Oncogene·2016
Same author

Induction of the intestinal stem cell signature gene SMOC-2 is required for L1-mediated colon cancer progression.

Oncogene·2015
Same author

Prevalence of Scedosporium species and Lomentospora prolificans in patients with cystic fibrosis in a multicenter trial by use of a selective medium.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2015
Same author

Molecular weight and molar substitution are more important in HES-induced renal impairment than concentration after hemorrhagic and septic shock.

Minerva anestesiologica·2014
Same author

[Fungal infections of the central nervous system in the immunocompetent host].

Der Pathologe·2013

Spinal muscular atrophy (SMA) is a genetic disease affecting motor neurons. Increased SMN2 gene copies correlate with milder SMA, offering therapeutic insights.

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Spinal muscular atrophy (SMA) is a hereditary neurodegenerative disorder caused by SMN1 gene defects.
  • SMA severity varies, from severe (SMA 1) to milder forms (SMA 3), influenced by SMN2 gene copy number.
  • The SMN protein's role in motoneuron RNA metabolism and apoptosis is under investigation.

Purpose of the Study:

  • To review the genetic basis and pathogenesis of SMA.
  • To discuss the role of the SMN2 gene in modulating SMA severity.
  • To explore recent advances in SMA mouse models for therapeutic development.

Main Methods:

  • Analysis of genetic evidence linking SMN1 mutations and SMN2 copy number to SMA.
  • Review of existing motoneuron disease mouse models and their limitations for SMA.

Related Experiment Videos

  • Description of newly developed genetic mouse models for SMA research.

    • Main Results:

    • SMN2 gene copy number and SMN protein levels are inversely correlated with SMA disease severity.
    • New genetic mouse models accurately replicate SMA characteristics, aiding pathogenesis studies.
    • These models are instrumental for evaluating novel therapeutic strategies.

    Conclusions:

    • SMN2 is a key determinant of SMA clinical presentation.
    • Advanced genetic mouse models are critical for understanding SMA pathogenesis.
    • Therapeutic strategies targeting SMN expression and neuroprotection show promise for SMA treatment.